Viewing Study NCT01577550


Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2026-04-23 @ 4:38 PM
Study NCT ID: NCT01577550
Status: COMPLETED
Last Update Posted: 2016-11-16
First Post: 2012-04-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Single Rising Dose Study of BI 655066 in Patients With Moderate and Severe Psoriasis
Sponsor: AbbVie
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Psoriasis View
Keywords:

Keywords

Keyword Brief Keyword Text View
None ABBV-066 View
None BI 655066 View
None risankizumab View